Literature DB >> 7030903

Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver.

F Bonino, B Hoyer, J Nelson, R Engle, G Verme, J Gerin.   

Abstract

Sera and liver biopsies from 30 Italian patients, carriers of HBsAg for at least 3 years, were examined for markers of hepatitis B virus (HBV) infection by serological assays and immunofluorescence. Biopsies were analyzed for HBcAg, HBsAg, and delta antigen by immunofluorescence; sera were assayed for HBsAg/anti-HBs, HBcAg/anti-HBc, HBeAg/anti-HBe, delta/anti-delta, HBV-specific DNA polymerase activity and the presence of HBV DNA. HBcAg, HBeAg, and DNA polymerase tests were positive in the sera of 71, 86, and 57%, respectively, of carriers with intrahepatic HBcAg. HBV DNA was detected in 100% of patients expressing HBcAg in the liver with a strong correlation between the concentration of serum DNA and the intensity of HBcAg immunofluorescence in the liver. HBV DNA was detected in the sera of 63% of carriers with intrahepatic delta where the other markers of HBV replication (HBeAg, DNA polymerase) were undetectable. The assay for serum HBV DNA appears to be an excellent noninvasive method for detecting active replication of HBV in HBsAg carriers.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030903     DOI: 10.1002/hep.1840010503

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  42 in total

1.  Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

Authors:  M R Brunetto; M M Giarin; F Oliveri; E Chiaberge; M Baldi; A Alfarano; A Serra; G Saracco; G Verme; H Will
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Digoxigenin-labeled probes for the detection of hepatitis B virus DNA in serum.

Authors:  K J Guo; D S Bowden
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Hepatocyte expression of HBcAg and serum HBeAg in hepatitis B: comparison of polyclonal and monoclonal antibodies during a trial of interferon.

Authors:  C M Chu; S M Lin; Y F Liaw
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

4.  Perinatal hepatitis B virus infection caused by antihepatitis Be positive maternal mononuclear cells.

Authors:  H Shimizu; T Mitsuda; S Fujita; S Yokota
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

5.  Relationship between the intrahepatic expression of 'e' and 'c' epitopes of the nucleocapsid protein of hepatitis B virus and viraemia.

Authors:  M Ballaré; C Lavarini; M R Brunetto; E Petruzzelli; M Dovis; G Molino; F Bonino
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

6.  Molecular hybridization methods for determination of serum HBV-DNA.

Authors:  T Arima; S Torigoe; H Hada; S Morichika; K Togawa; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-10

7.  Evaluation of the commercially available HepProbe kit for detection of hepatitis B virus DNA in serum.

Authors:  E Valentine-Thon; J Steinmann; W Arnold
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

8.  Detection of hepatitis B virus DNA in chronic carriers of hepatitis B surface antigen in southwestern Greece.

Authors:  M Christofidou; A Athanassiadou; A Skoutelis; E D Anastassiou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

9.  Screening for hepatitis B virus in healthy blood donors by molecular DNA hybridization analysis.

Authors:  C F Sun; C C Pao; S Y Wu; Y F Liaw
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

10.  Multiplication of hepatitis B virus in fulminant hepatitis B.

Authors:  C Brechot; J Bernuau; V Thiers; F Dubois; A Goudeau; B Rueff; P Tiollais; J P Benhamou
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.